MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma
about
MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasisMicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.Reduced miR-125a levels associated with poor survival of patients with hepatocellular cancer.Association of miR-21, miR-126 and miR-605 gene polymorphisms with ischemic stroke risk.Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
P2860
MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
MicroRNA-34a expression levels ...... with hepatocellular carcinoma
@en
MicroRNA-34a expression levels ...... with hepatocellular carcinoma.
@nl
type
label
MicroRNA-34a expression levels ...... with hepatocellular carcinoma
@en
MicroRNA-34a expression levels ...... with hepatocellular carcinoma.
@nl
prefLabel
MicroRNA-34a expression levels ...... with hepatocellular carcinoma
@en
MicroRNA-34a expression levels ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-34a expression levels ...... with hepatocellular carcinoma
@en
P2093
Xiao-Mei Zhao
Zhao-Chong Zeng
Zhao-You Tang
Zuo-Lin Xiang
P2860
P304
87246-87256
P356
10.18632/ONCOTARGET.13531
P407
P50
P577
2016-11-23T00:00:00Z